Study details
Enrolling now
Rapamycin Trial for Memory Problems
The University of Texas Health Science Center at San Antonio
NCT IDNCT04629495ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
40
Study length
about 4.6 years
Ages
55–89
Locations
1 site in TX
What this study is about
This trial is testing the safety of rapamycin, a drug, in older adults with memory problems. The goal is to see if this treatment can be safely given and how well it works over 1693 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Rapamycin
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
sirolimus
Endpoints
Primary: Number of adverse events
Secondary: Change in Functional status, Change in Gait Speed, Change in Grip Strength, Change in Neuropsychiatric symptoms
Body systems
Neurology